Cambridge, UK, 27 August 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today introduced an updated version of its Cyto-Mine® Studio Software Suite, a collection of software controlling operation of its Cyto-Mine Single Cell Analysis System, data acquisition and follow-up analysis. The latest software version includes new functionality to further enhance users’ workflows in biologics discovery and cell line development.
News
20th August 2019: Marks & Clerk, the UK’s largest Patent and Trade Mark Attorney firm, has boosted its team in Cambridge with the promotion of two new Partners. Steven Gurney, a specialist in the pharmaceutical sector and Matthew Pinney who specialises in software and telecommunications, both join the Marks & Clerk partnership.
The firm, which alongside its office in Cambridge has bases across the UK as well as in the EU, North America and Asia, is one of Europe’s largest teams of intellectual property specialists.
Cambridge, UK, 21 August 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has opened a new office space at Granta Park in Cambridgeshire, UK. The new facilities support the Company’s accelerated expansion and accommodate its plans for further growth.
Cambridge, UK, 20 August: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, is delighted to welcome Tim Rea, an investor at BGF, to its board.
Tim has been active in the venture capital and start-up ecosystem for over 20 years across a broad range of sectors, stages and geographies. He is particularly passionate about the application of new, disruptive technologies into the healthcare and life sciences ecosystems.
This research, which investigates the risk of drug-induced folate deficiency with HIV integrase inhibitors, was published in Drug Metabolism and Disposition (DMD)
QxMD Builds on Medscape’s Point-of-Care Tools and Services
New York, NY, August 12, 2019: WebMD Health Corp., an Internet Brands company and the leader in health information services for physicians and consumers, has acquired QxMD, a Vancouver, BC-based learning technology company that delivers mobile decision point tools and personalized learning solutions for physicians and health care professionals (HCPs).
Kadans expands its presence in the United Kingdom by adding its second research hub in the country to its Pan-European science park portfolio.
Kadans acquired Sycamore House from GSK. It is a 9,640 sqm industrial and warehouse building, located directly adjacent to Stevenage Bioscience Catalyst (“SBC”), and the Cell and Gene Therapy Catapult Manufacturing Centre (“CGTCMC”). Kadans will redevelop and extend Sycamore House into a modern, vibrant, multi-tenanted R&D facility with expected completion mid-2021.
CAMBRIDGE, UK, 09 August 2019 – Start Codon, a new model of life science and healthcare business accelerator, today announced it has partnered with Clustermarket, a leading online equipment sharing and booking platform and Science Entrepreneur Club, a life sciences network, to help drive the translation of world-class life science and healthcare research into commercially successful companies.
This transaction increases BioIVT’s portfolio of disease-state plasma, sera and controls, and enhances its ability to support the in vitro diagnostic market
Westbury, NY – Aug. 6, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. This acquisition will expand BioIVT’s disease-state portfolio both by volume and product range.